Phase II, randomized, double-blind placebo-controlled trial of nimotuzumab plus gemcitabine compared with gemcitabine alone in patients (pts) with advanced pancreatic cancer (PC)
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31, (Summary Text)
- Publication Type: Conference Paper / Summary Text
- Volume: 31
- City: Illinois
- Country: United States Of America
- Hacettepe University Affiliated: Yes